Exploring muscle relaxation strategies to mitigate anxiety and enhancing the quality of sleep in COVID-19 survivors

Background: Because of their regular isolation, patients with COVID-19 had high levels of anxiety and irregular sleep patterns. Certain sleep-enhancing medications may hinder the aerobic system and exacerbate the illness. lengthen the bedside, which could increase the risk of medical infections. Objective: To determine how COVID-19 survivors’ anxiety and sleep quality are affected by progressive muscle relaxation. Methods: A total of 146 Jordanian patients who were admitted to the isolation suite were chosen at random to be placed in the experimental and control groups. For five days in a row, the experimental group used progressive muscle relaxation (PMR) technology for 30 min each day. The control group received only standard medical attention and medication. The Spielberg State-Trait Anxiety Scale (STAI) and Sleep State Self Rating Scale (SRSS) were used to measure patient anxiety and sleep quality before and after the intervention. Ultimately, SPSS 25.0 was used to analyze the data. Results: Prior to intervention, the average anxiety score (STAI) was not statistically significant (P = 0.89); however, following the intervention, it became statistically significant (P < 0.05). Prior to interventions, the two groups’ average sleep quality scores (SRSS) were not statistically significant (P = 0.71), but they were after the interventions (P < 0.05). Conclusion: As an adjunctive technique, progressive muscle relaxation helps lower anxiety and enhance the quality of sleep for COVID-19 survivors.